Avant Bio
VC firm · New York, NY
SEC-registered adviser
Venture firm based in New York, NY. Most recent fund on file: Avant Bio Fund II LP ($57.5M offering), filed Dec 2024. Partners sit on the boards of 3 startups that raised recently.
- Stages
- Series A to Growth
- Typical check (est.)
- $575K–$1.7M
- Latest fund
- $57.5M · Dec 2024
- Last verified activity
- Mar 2024
Focus
Biotech & PharmaCybersecurityRecent portfolio activity
Funds and vehicles on SEC file
- Dec 2024
Avant Bio Fund II LP
Fund · $57.5M offering
Sources
- SEC Form D: Avant Bio Fund II LPDec 23, 2024
- SEC adviser record: Avant BIO LLCMar 31, 2026
- Firm websiteOct 12, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.